According to the research report titled ‘Global Gel Implants Market Size study, By Type (Cohesive Gel Implants, Highly Cohesive Gel Implants, Gummy Bear Gel Implants), By Indication (Cosmetic Surgery, Reconstruction Surgery, Preventive Surgery), By End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers), By Shape (Round, Anatomical, Tear Drop) and Regional Forecasts 2021-2027’, available with Market Study Report LLC, global gel implants market is expected to register 3.1% CAGR during 2021-2027.
 

High prevalence of breast cancer and growing focus towards physical aesthetic appeal are the major factors driving the growth of global gel implants market. According to the WHO, around 2.3 million women were diagnosed with breast cancer in 2020, with mortality numbers reaching 685,000 in the same year.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4566344/
 

Gel implants are essentially filled with gels and are known to be relatively similar to natural breast tissues. It is widely used for cosmetic surgery, preventive treatments, or reconstruction surgeries. Thus, surging investments towards using cosmetics and rising fashion cognizance have impelled the demand for gel implants across the globe.
 

On the contrary, threat of substitutes could hamper global gel implants market remuneration in the ensuing years.
 

Regionally, North America accounts for the largest share in global gel implants market and is likely to showcase consistent growth during the study period, owing to high awareness regarding breast cancer and rising adoption of gel implants.
 

Europe is also expected to emerge as a key revenue generator for the market majors by the year 2027, on account of increased pervasiveness of breast cancer and rising disposable income.
 

The competitive landscape of global gel implants market is defined by companies such as Silimed Inc., Ideal Implant Inc., Guangzhou Wanhe Plastic Materials Co. Ltd., Hans Biomed Co. Ltd., POLYTECH Health & Aesthetics GmbH, Groupe Sebbin SAS, Sientra Inc., GC Aesthetics plc, Mentor Worldwide LLC, Establishment Labs Holdings Inc., Cereplas, Laboratoires Arion, and Allergan Inc.